Call for Postdoctoral Fellowship Applications: Program On Regulation, Therapeutics, And Law (PORTAL) - Harvard Medical School/Brigham and Women’s Hospital

CLOSING DATE: December 20, 2018


JOB #: 13314

POSTED: November 20, 2018


The Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital Department of Medicine and Harvard Medical School invites its 2019 round of applications for postdoctoral fellows in pharmaceutical law and health services research. Current and past fellows have studied FDA regulation, patents, prescription drug prices, and competition in the therapeutic marketplace. Other areas of focus include intellectual property, ethics, and comparative effectiveness, as well as the development, approval, and evidence-based use of drugs, devices, vaccines, procedures, and diagnostics.


The Division of Pharmacoepidemiology and Pharmacoeconomics is a 60-member interdisciplinary research center. Our work focuses on the evaluation, regulation, outcomes, and cost-effectiveness of prescription drugs and medical devices, as well as the development and evaluation of policies to improve use of therapeutics. 


Applications are invited from researchers with doctoral degrees (J.D., M.D., Ph.D., Pharm.D., or equivalent) or who will complete such training by July 2019. Fellows will have an appointment at Harvard Medical School, receive close mentorship from faculty members in the Division, and engage in one or more projects intended to start their careers in law and public health research. Salary level and fellowship length will vary depending on the candidate (minimum: 1 year). 

How to Apply:

The deadline is January 25, 2019. To apply, please send to (1) a CV, (2) a writing sample, and (3) a cover letter describing your past work, ideas for the kinds of research you’d like to do in the fellowship, and career goals. 


E-mail Ameet Sarpatwari, J.D., Ph.D. at with any questions.


Brigham and Women’s Hospital and Harvard Medical School are Equal Opportunity/Affirmative Action Employers; women and members of underrepresented minority groups are strongly encouraged to apply.